GILD

Gilead Sciences
D

GILD

Arincen87/100B
166.870
USD
-0.73
(-0.44%)
Pre Open·168.040USD+1.170(+0.70%)
Last updated: · Delayed 15 min

Who owns Gilead Sciences?

Institutions own 90.2% of Gilead Sciences's shares, through 2,377 funds, banks and other managers that report their holdings to the SEC; individual investors and others hold the rest. The largest on 30 June 2026 were BlackRock, Inc. (9.8%), Vanguard Capital Management LLC (6.5%), FMR LLC (5.4%).

Institutions own
90.2%
Institutional holders
2,377
The 10 largest hold
42.7%
Free float
99.8%
Holdings as of
30 Jun 2026

Who owns the shares

10 largest holders 42.7% Other institutions 47.4% Individuals and others 9.8%

Shares free to trade

Free float 1.24B shares ·99.8% Closely held 2.63M shares ·0.2%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

The largest shareholders

#HolderSharesOf the companyValueChange last quarter (shares)
1BlackRock, Inc.121,844,1089.80%15.39B USD+2,833,135
2Vanguard Capital Management LLC81,091,7346.52%10.25B USD+436,958
3FMR LLC66,870,8165.38%8.45B USD-5,035,474
4State Street Corp61,216,5524.93%7.73B USD+1,357,967
5Capital World Investors40,988,9753.30%5.18B USD-294,958
6Invesco Ltd.39,819,1513.20%5.03B USD+13,764,664
7Vanguard Portfolio Management LLC35,316,1682.84%4.46B USD+186,703
8Geode Capital Management, LLC30,065,6422.42%3.80B USD+339,590
9Price T Rowe Associates Inc29,996,6942.41%3.79B USD+3,748,586
10Morgan Stanley24,004,3541.93%3.03B USD+705,059

All institutions last quarter

Bought or added
1,266 · 158 new
Sold or cut
1,064 · 194 sold out
Net shares bought
+46.19M · 5.84B USD
Institutional ownership
86.3% → 90.2%

Biggest buyers last quarter

  • Norges BankNew position
  • Invesco Ltd.+13,764,664
  • Sixth Street Partners Management Company, L.P.New position
  • Sg Americas Securities, LLC+3,812,458
  • Price T Rowe Associates Inc+3,748,586

Biggest sellers last quarter

  • JPMorgan Chase & Co-13,171,789
  • Capital Research Global Investors-7,734,237
  • FMR LLC-5,035,474
  • Td Asset Management Inc-1,400,496
  • Bank Of America Corp-1,329,871

From the holders' 13F filings with the SEC for the quarter to 30 Jun 2026, filed up to 45 days after it; the buyers and sellers are among the 100 largest holders.

Common questions about Gilead Sciences's shareholders

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.